GENE ONLINE|News &
Opinion
Blog

Clinical Trial
Citius Pharma Makes Calculated Market Moves with Phase 3 Results Looming for Potential Blockbuster Product
2021-02-21
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
Bristol Myers Squibb Registers Another Trial Win for its Psoriasis Med
2021-02-03
Immutep Announces Discontinuation of Phase 2 Ulcerative Colitis Study by GSK
2021-01-30
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
Merck and Bayer Enter the Congested Market of Heart Failure with Verquvo
2021-01-21
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
Philippines Signs Second Vaccine Deal to Procure 30 Million Doses of Novavax’s Covovax
2021-01-12
Sarepta’s Stocks Drop 50% Following Middling Trial Data for Gene Therapy
2021-01-11
Imara’s Sickle Cell Disease Therapy Impresses in Phase 2 Trial
2021-01-09
Alnylam Nears Fourth Approval with Successful Trial Data for RNAi Drug
2021-01-08
Lynparza Bags Multiple Approvals in Japan
2021-01-05
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Voyager Encounters Regulatory Bump in Parkinson’s Trial
2020-12-25
uniQure’s Hemophilia B Gene Therapy Put on Clinical Hold by the FDA
2020-12-22
1 2 3 4 5 6 14
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top